⌘K

Login Start Free

Home/Filings/4/0001562180-21-000933

4//SEC Filing

Karydas Daphne 4

Accession 0001562180-21-000933

CIK 0001395937other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:22 PM ET

Size

5.4 KB

Accession

0001562180-21-000933

Insider Transaction Report

Form 4

Period: 2021-02-03

Syndax Pharmaceuticals IncSNDX

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-02-03+95,000→ 95,000 total
Exercise: $21.36Exp: 2031-02-03→ Common Stock (95,000 underlying)

Footnotes (1)

[F1]1/48th of the shares subject to the option shall vest monthly over a four-year period.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1

filerCIK 0001816952

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 4:22 PM ET
Size: 5.4 KB

View on SEC.gov